Global CAR T-cell Therapy Market 2025-2029

Car T-Cell Therapy Market 2025-2029


The car t-cell therapy market is forecasted to grow by $ 3557.3 mn during 2024-2029, accelerating at a CAGR of 17.3% % during the forecast period. The report on the car t-cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness regarding car t-cell therapy, increasing prevalence of blood cancer, and increasing incidence of hematological malignancies.

Technavio's car t-cell therapy market is segmented as below:

By End-user
  • Hospitals
  • Cancer treatment centers
By Type
  • CD19
  • CD22
  • BCMA
  • Others
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising number of product approvals and clinical trials related to car t- cell therapy as one of the prime reasons driving the car t-cell therapy market growth during the next few years. Also, growing investments in research and development to remodel design of car-t therapy and growing number of collaborations and partnerships will lead to sizable demand in the market.

The report on the car t-cell therapy market covers the following areas:
  • Car T-Cell Therapy Market sizing
  • Car T-Cell Therapy Market forecast
  • Car T-Cell Therapy Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading car t-cell therapy market vendors that include ACROBIOSYSTEMS INC., Allogene Therapeutics Inc., Bristol Myers Squibb Co., Celyad Oncology SA, Eli Lilly and Co., Fate Therapeutics Inc., Fortress Biotech Inc., Gilead Sciences Inc., GSK Plc, Johnson and Johnson Inc., Les Laboratoires Servier, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Noile Immune Biotech Inc., Novartis AG, Pfizer Inc., Sangamo Therapeutics Inc, and Sorrento Therapeutics Inc.. Also, the car t-cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global CAR T-Cell Therapy Market 2019 - 2023
Historic Market Size - Data Table on Global CAR T-Cell Therapy Market 2019 - 2023 ($ million)
5.2 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the global CAR T-cell therapy market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by End-user
8.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
8.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Cancer treatment centers - Market size and forecast 2024-2029
Chart on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Data Table on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Chart on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
Data Table on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 CD19 - Market size and forecast 2024-2029
Chart on CD19 - Market size and forecast 2024-2029 ($ million)
Data Table on CD19 - Market size and forecast 2024-2029 ($ million)
Chart on CD19 - Year-over-year growth 2024-2029 (%)
Data Table on CD19 - Year-over-year growth 2024-2029 (%)
9.4 CD22 - Market size and forecast 2024-2029
Chart on CD22 - Market size and forecast 2024-2029 ($ million)
Data Table on CD22 - Market size and forecast 2024-2029 ($ million)
Chart on CD22 - Year-over-year growth 2024-2029 (%)
Data Table on CD22 - Year-over-year growth 2024-2029 (%)
9.5 BCMA - Market size and forecast 2024-2029
Chart on BCMA - Market size and forecast 2024-2029 ($ million)
Data Table on BCMA - Market size and forecast 2024-2029 ($ million)
Chart on BCMA - Year-over-year growth 2024-2029 (%)
Data Table on BCMA - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
11.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
11.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.12 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
11.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
11.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 ACROBIOSYSTEMS INC.
ACROBIOSYSTEMS INC. - Overview
ACROBIOSYSTEMS INC. - Product / Service
ACROBIOSYSTEMS INC. - Key offerings
SWOT
14.5 Allogene Therapeutics Inc.
Allogene Therapeutics Inc. - Overview
Allogene Therapeutics Inc. - Product / Service
Allogene Therapeutics Inc. - Key offerings
SWOT
14.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
14.7 Celyad Oncology SA
Celyad Oncology SA - Overview
Celyad Oncology SA - Product / Service
Celyad Oncology SA - Key offerings
SWOT
14.8 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
14.9 Fate Therapeutics Inc.
Fate Therapeutics Inc. - Overview
Fate Therapeutics Inc. - Product / Service
Fate Therapeutics Inc. - Key offerings
SWOT
14.10 Fortress Biotech Inc.
Fortress Biotech Inc. - Overview
Fortress Biotech Inc. - Business segments
Fortress Biotech Inc. - Key offerings
Fortress Biotech Inc. - Segment focus
SWOT
14.11 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
SWOT
14.12 GSK Plc
GSK Plc - Overview
GSK Plc - Business segments
GSK Plc - Key news
GSK Plc - Key offerings
GSK Plc - Segment focus
SWOT
14.13 Johnson and Johnson Inc.
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key news
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Segment focus
SWOT
14.14 Miltenyi Biotec B.V. and Co. KG
Miltenyi Biotec B.V. and Co. KG - Overview
Miltenyi Biotec B.V. and Co. KG - Product / Service
Miltenyi Biotec B.V. and Co. KG - Key news
Miltenyi Biotec B.V. and Co. KG - Key offerings
SWOT
14.15 Noile Immune Biotech Inc.
Noile Immune Biotech Inc. - Overview
Noile Immune Biotech Inc. - Product / Service
Noile Immune Biotech Inc. - Key offerings
SWOT
14.16 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
14.17 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
14.18 Sorrento Therapeutics Inc.
Sorrento Therapeutics Inc. - Overview
Sorrento Therapeutics Inc. - Business segments
Sorrento Therapeutics Inc. - Key offerings
Sorrento Therapeutics Inc. - Segment focus
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global CAR T-Cell Therapy Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on End-user - Market share 2024-2029 (%)
Exhibits37: Data Table on End-user - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by End-user
Exhibits39: Data Table on Comparison by End-user
Exhibits40: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
Exhibits48: Market opportunity by End-user ($ million)
Exhibits49: Data Table on Market opportunity by End-user ($ million)
Exhibits50: Chart on Type - Market share 2024-2029 (%)
Exhibits51: Data Table on Type - Market share 2024-2029 (%)
Exhibits52: Chart on Comparison by Type
Exhibits53: Data Table on Comparison by Type
Exhibits54: Chart on CD19 - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on CD19 - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on CD19 - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on CD19 - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on CD22 - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on CD22 - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on CD22 - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on CD22 - Year-over-year growth 2024-2029 (%)
Exhibits62: Chart on BCMA - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on BCMA - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on BCMA - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on BCMA - Year-over-year growth 2024-2029 (%)
Exhibits66: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits67: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits68: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits69: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits70: Market opportunity by Type ($ million)
Exhibits71: Data Table on Market opportunity by Type ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits81: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits133: Market opportunity By Geographical Landscape ($ million)
Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits135: Impact of drivers and challenges in 2024 and 2029
Exhibits136: Overview on criticality of inputs and factors of differentiation
Exhibits137: Overview on factors of disruption
Exhibits138: Impact of key risks on business
Exhibits139: Companies covered
Exhibits140: Company ranking index
Exhibits141: Matrix on companies position and classification
Exhibits142: ACROBIOSYSTEMS INC. - Overview
Exhibits143: ACROBIOSYSTEMS INC. - Product / Service
Exhibits144: ACROBIOSYSTEMS INC. - Key offerings
Exhibits145: SWOT
Exhibits146: Allogene Therapeutics Inc. - Overview
Exhibits147: Allogene Therapeutics Inc. - Product / Service
Exhibits148: Allogene Therapeutics Inc. - Key offerings
Exhibits149: SWOT
Exhibits150: Bristol Myers Squibb Co. - Overview
Exhibits151: Bristol Myers Squibb Co. - Product / Service
Exhibits152: Bristol Myers Squibb Co. - Key news
Exhibits153: Bristol Myers Squibb Co. - Key offerings
Exhibits154: SWOT
Exhibits155: Celyad Oncology SA - Overview
Exhibits156: Celyad Oncology SA - Product / Service
Exhibits157: Celyad Oncology SA - Key offerings
Exhibits158: SWOT
Exhibits159: Eli Lilly and Co. - Overview
Exhibits160: Eli Lilly and Co. - Product / Service
Exhibits161: Eli Lilly and Co. - Key offerings
Exhibits162: SWOT
Exhibits163: Fate Therapeutics Inc. - Overview
Exhibits164: Fate Therapeutics Inc. - Product / Service
Exhibits165: Fate Therapeutics Inc. - Key offerings
Exhibits166: SWOT
Exhibits167: Fortress Biotech Inc. - Overview
Exhibits168: Fortress Biotech Inc. - Business segments
Exhibits169: Fortress Biotech Inc. - Key offerings
Exhibits170: Fortress Biotech Inc. - Segment focus
Exhibits171: SWOT
Exhibits172: Gilead Sciences Inc. - Overview
Exhibits173: Gilead Sciences Inc. - Product / Service
Exhibits174: Gilead Sciences Inc. - Key news
Exhibits175: Gilead Sciences Inc. - Key offerings
Exhibits176: SWOT
Exhibits177: GSK Plc - Overview
Exhibits178: GSK Plc - Business segments
Exhibits179: GSK Plc - Key news
Exhibits180: GSK Plc - Key offerings
Exhibits181: GSK Plc - Segment focus
Exhibits182: SWOT
Exhibits183: Johnson and Johnson Inc. - Overview
Exhibits184: Johnson and Johnson Inc. - Business segments
Exhibits185: Johnson and Johnson Inc. - Key news
Exhibits186: Johnson and Johnson Inc. - Key offerings
Exhibits187: Johnson and Johnson Inc. - Segment focus
Exhibits188: SWOT
Exhibits189: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits190: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibits191: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibits192: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits193: SWOT
Exhibits194: Noile Immune Biotech Inc. - Overview
Exhibits195: Noile Immune Biotech Inc. - Product / Service
Exhibits196: Noile Immune Biotech Inc. - Key offerings
Exhibits197: SWOT
Exhibits198: Novartis AG - Overview
Exhibits199: Novartis AG - Business segments
Exhibits200: Novartis AG - Key news
Exhibits201: Novartis AG - Key offerings
Exhibits202: Novartis AG - Segment focus
Exhibits203: SWOT
Exhibits204: Pfizer Inc. - Overview
Exhibits205: Pfizer Inc. - Product / Service
Exhibits206: Pfizer Inc. - Key news
Exhibits207: Pfizer Inc. - Key offerings
Exhibits208: SWOT
Exhibits209: Sorrento Therapeutics Inc. - Overview
Exhibits210: Sorrento Therapeutics Inc. - Business segments
Exhibits211: Sorrento Therapeutics Inc. - Key offerings
Exhibits212: Sorrento Therapeutics Inc. - Segment focus
Exhibits213: SWOT
Exhibits214: Inclusions checklist
Exhibits215: Exclusions checklist
Exhibits216: Currency conversion rates for US$
Exhibits217: Research methodology
Exhibits218: Information sources
Exhibits219: Data validation
Exhibits220: Validation techniques employed for market sizing
Exhibits221: Data synthesis
Exhibits222: 360 degree market analysis
Exhibits223: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings